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Mechanical Defects of Muscle Fibers with Myosin Light Chain
Mutants that Cause Cardiomyopathy
Osha Roopnarine
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Medical School, Minneapolis, Minnesota
ABSTRACT Familial hypertrophic cardiomyopathy is a disease caused by single mutations in several sarcomeric proteins,
including the human myosin ventricular regulatory light chain (vRLC). The effects of four of these mutations (A13T, F18L, E22K,
and P95A) in vRLC on force generation were determined as a function of Ca21 concentration. The endogenous RLC was
removed from skinned rabbit psoas muscle ﬁbers, and replaced with either rat wildtype vRLC or recombinant rat vRLC (G13T,
F18L, E22K, and P95A). Compared to ﬁbers with wildtype rat vRLC, the E22K mutant increased Ca sensitivity of force
generation, whereas the G13T and F18L mutants decreased the Ca sensitivity, and the P95A mutant had no signiﬁcant effect.
None of the RLC mutants affected the maximal tension (observed at saturating Ca21 concentrations), except for F18L, which
decreased the maximal tension to 69 6 10% of the wildtype value. Of the mutant RLCs, only F18L decreased the cooperativity
of activation of force generation. These results suggest that the primary cause of familial hypertrophic cardiomyopathy, in some
cases, is perturbation in the Ca sensitivity of force generation, in which Ca-sensitizing or Ca-desensitizing effects can lead to
similar disease phenotypes.
INTRODUCTION
Familial hypertrophic cardiomyopathy (FHC) is a genetic
human heart disease that is phenotypically variable, with
features ranging from severe (sudden death) to intermediate
to benign (near normal life span). The disease is classically
characterized by hypertrophy of the left ventricle and
intraventricular septum, myocardial cellular disarray, myo-
ﬁlament disarray, and interstitial myocardial ﬁbrosis. It is
typically caused by mutations in cardiac sarcomeric proteins:
b-myosin heavy chain, a-tropomyosin, myosin binding
protein-C, ventricular essential light chain (vELC), ventric-
ular regulatory light chain (vRLC), troponin I, actin, titin,
and troponin T (Roopnarine, 2002; Seidman and Seidman,
2001; Rayment et al., 1995; Bonne et al., 1998; Hernandez
et al., 2001; Michele and Metzger, 2000). Most of the muta-
tions are located either in or near functional regions of the
mutant proteins (Rayment et al., 1995), suggesting that the
molecular mechanism for the FHC disease is related to
the dysfunction (either enhanced or diminished function) of
the mutant sarcomeric protein. The focus of this paper is to
determine the Ca sensitivity of force generation in skeletal
muscle ﬁbers containing the myosin RLC mutations that
cause FHC. The results in this paper provide evidence that
links some of the FHC-RLC mutations to mechanical dys-
function of the muscle ﬁber, due to impaired Ca sensitivity of
force generation.
Myosin is a dimer that is folded symmetrically into two
heads and a tail, each monomer containing a myosin heavy
chain, an essential light chain, and a regulatory light chain.
The myosin head contains the catalytic domain (ATPase site
and actin binding sites) and the LC domain (ELC and RLC).
Several FHC mutations have been found in vRLC: A13T,
E22K, P95A (Poetter et al., 1996), F18L, R58Q (Flavigny
et al., 1998), and N47K (Andersen et al., 2001) (Fig. 1). In
addition to having the classical FHC disease phenotype,
A13T and E22K result in a rare myopathy in the heart
(midventricular chamber thickening), and E22K patients
exhibit red ragged ﬁber histology in the slow skeletal muscle
(Poetter et al., 1996). These FHC mutations are near the
functional regions of the RLC, and the native amino acids are
highly conserved across species and isoforms (Poetter et al.,
1996; Flavigny et al., 1998). A13T, F18L, and E22K are near
the phosphorylation site in vRLC, Ser 15. P95A is in the
linker region between the N-terminal and C-terminal do-
mains of RLC. The C-terminal and linker region of RLC in-
teract with the myosin heavy chain (Rayment et al., 1993).
N47K and R58Q are near the Ca binding site of RLC.
In most current models of muscle contraction, the LC
domain of myosin plays a key role in contraction, acting
as a lever arm that tilts as myosin changes its actin-bound
conﬁguration fromweak to strong (Thomas et al., 2002). Elec-
tron paramagnetic resonance studies have shown that the
myosin LC domain undergoes a dynamic disorder-to-order
transition during muscle contraction (Roopnarine et al.,
1998), during which the LC domain rotates through a large
angle (Baker et al., 1998). In striatedmuscle contraction, RLC
modulates crossbridge contractility by altering myosin’s
interactions with actin. Phosphorylation of RLC increases
the submaximal isometric tension, induces a leftward shift in
the tension-pCa curve, but does not change the maximal
isometric tension (Persechini et al., 1985), and increases the
rate of force development (Metzger et al., 1989). Replacement
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of the phosphorylatable serines (Ser 14, 15, and 19) with
alanines in mouse vRLC induces a variety of negative
cardiovascular changes in transgenic mice (Sanbe et al.,
1999). Furthermore, the importance of vRLC for normal
mammalian cardiac function is demonstrated by the correla-
tions with human diseases. vRLC phosphorylation is de-
creased during heart failure (Morano, 1992), and in diabetic
cardiomyopathic rats (30–40% decrease; see Liu et al., 1997).
In contrast, RLC phosphorylation is elevated in rats during
increased beat frequency or left ventricular pressure due to
exercise or inotropic agents (Fitzsimons et al., 1990).
The molecular mechanisms by which FHC mutations
cause cardiac hypertrophy and myocyte disarray are not
clearly understood. Previous studies of several FHC-mutant
myosins showed decreased myosin ATPase activity (Roop-
narine and Leinwand, 1998), actin motility, and force, sup-
porting a hypothesis that a hypocontractile state induces
hypertrophy (Bonne et al., 1998). In contrast, other
functional studies on FHC mutations show increased Ca
sensitivity of force, supporting a hypothesis that a hyper-
contractile state induces hypertrophy (Bonne et al., 1998).
This was observed for the R403Q myosin FHC mutation
(Seidman and Seidman, 2001) and several of the troponin
T, TnI (Hernandez et al., 2001), and Tm FHC mutations
(Michele and Metzger, 2000). In addition, some FHC mu-
tations show insigniﬁcant functional defects in vitro, but
still have the phenotype of the FHC disease (Bonne et al.,
1998), thus complicating the elucidation of molecular mech-
anisms for the disease.
Functional studies have been done on only one of the
FHC-RLC mutations (E22K). Myosin isolated from cardiac
biopsies (from a patient with E22K) induced normal actin
ﬁlament motility (Poetter et al., 1996), but slow skeletal
ﬁbers from an E22K-diseased patient increased Ca sensitiv-
ity of force (Levine et al., 1998). Transgenic mice expressing
E22K in the heart did not show any features of the FHC
disease despite almost total replacement of the endogenous
wildtype vRLC with mutant vRLC (Sanbe et al., 2000). The
Ca-binding afﬁnities of several of the FHC-RLC mutations
are diminished in RLC isolated in solution, but are unknown
when RLC is bound to myosin in solution or in muscle ﬁbers
(Szczesna et al., 2001). In addition, the effect of these mu-
tations on the Ca sensitivity of force within muscle ﬁbers was
not previously studied.
In the present report, the Ca sensitivity of force due to
the FHC-RLC mutations (A13T, F18L, E22K, and P95A)
was studied directly in rabbit psoas skeletal muscle ﬁbers. Rat
cardiac vRLC was used as the background for studying
the effect of the FHC-RLC mutations, in part because trans-
genic rodent models for myosin-FHC mutations were be-
ing developed in other laboratories (Sanbe et al., 2000) for
pathophysiological assessment of the disease. The amino acid
similarity between human vRLC and rat vRLC is 95.2%, with
100% similarity in the amino acids ﬂanking the FHCmutation
(except for A13T, as explained in Material and Methods).
Therefore, the rat vRLC is a good candidate for studying the
FHC mutations. Rabbit psoas ﬁbers were used instead of
human cardiac muscle ﬁbers because sufﬁcient quantity of
healthy human cardiac tissue was not readily available for this
study. More importantly, the present study used 5, 59-
dithiobis (2-nitrobenzoic acid) (DTNB) to extract RLC. This
procedure works in fast skeletal ﬁbers (Szczesna et al., 1996),
but not in soleus or cardiac ﬁbers (Wagner, 1982), probably
because fast skeletal RLC, but not vRLC, contains cysteines
that can react with DTNB (Huber et al., 1989). The RLC-
binding region of myosin heavy chain (808–842) contains
only one nonconservative amino acid difference between the
rabbit fast skeletal and cardiac b-myosin isoforms, therefore,
the binding of vRLC to rabbit fast myosin is unlikely to be
impaired. Therefore, it is likely that the functional effects of
mutations observed in the present study will provide useful
insight into physiological effects of the FHC mutations.
Therefore, in the present study, RLC was extracted from
skinned muscle ﬁber bundles, and then reconstituted with
either wildtype rat vRLC or with rat vRLC containing an
FHC mutation. The isometric force of single muscle ﬁbers
containing wildtype rabbit RLC, vRLC, or mutant vRLC
was determined as a function of Ca21 concentration. The
maximal isometric tension and cooperativity were not sig-
niﬁcantly affected for any mutation, except for F18L. All of
the mutations changed the Ca sensitivity of force generation
in ﬁbers, except for P95A. These results suggest that some
FHC-RLC mutations affect cardiac function by altering the
Ca sensitivity of force generation.
MATERIALS AND METHODS
Expression and puriﬁcation of RLC
Wildtype rat vRLC cDNA was subcloned into the pET-3d expression vector
(Novagen, Madison, WI), and the FHC mutations, G13T, F18L, E22K, and
FIGURE 1 Crystal structure of chicken skeletal myosin S1 (blue)
showing the location of the FHC mutations in RLC (red ): E22K, N47K,
R58Q, and P95A ( yellow). A13T and F18L are not shown because residues
1–19 are missing from the crystal structure (Rayment et al., 1993).
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P95A (Fig. 1) were introduced using the ‘‘QuikChange’’ mutagenesis kit
(Stratagene, La Jolla, CA). In rat vRLC, Ala13 is replaced by Gly, so a G13T
mutation was created in rat vRLC. The amino acid sequence identity of rat
vRLC (accession #x07314) compared to human vRLC (accession #x66141)
is 95.2% in 166 amino acid overlap (96% similarity), with four conserved
replacements and three amino acid differences (the human vRLC Ala10 is
replaced by Leu, Gly11 is replaced by Glu, Asn14 is replaced by Ser). The
mutant RLC genes were sequenced (Microchemical Facility, University of
Minnesota) to verify the presence of the engineered mutations, and then
transformed into an expression Escherichia coli cell line, JM109DE3, for
expression of RLC in luria broth media. RLC expression was induced by
addition of 0.4 mM IPTG to cells growing in log phase (OD600¼ 0.6–0.7) at
378C. The cells were then grown for an additional 3 h, and collected by
centrifugation at 6000 rpm for 5 min. The RLC was expressed in inclusion
bodies, which were released from the cells using a lysis buffer (25 mM Tris,
pH 8.0, 5 mMEDTA, 50 mM glucose, 1 mM PMSF, 1 mMDTT) containing
0.15 mg/ml lysozyme, followed by a freeze/thaw cycle, and incubation with
10 mM MgCl2 and 25mg/ml DNase I for 1 h on ice. The inclusion bodies
were isolated by centrifugation at 11,500 rpm in a SS34 rotor in a Sorvall
centrifuge for 25 min at 48C, washed in the lysis buffer1 0.1% triton3100
twice, then in ﬁnal triton-free lysis buffer. The RLC was released from the
inclusion bodies with 7 M urea in column buffer (50 mMMOPS, pH 6.5, 10
mM NaCl, 1 mM DTT), and puriﬁed on a DE52 anion exchange column
with a linear gradient of 0.01–0.5 M NaCl in 4 M urea in column buffer.
After puriﬁcation, the gradient fractions were analyzed by 15% SDS PAGE
for puriﬁed RLC, which was then dialyzed six times against 4 liters of 25
mM ammonium bicarbonate and 0.1 mM DTT. The RLC was puriﬁed to
near homogeneity, then lyophilized, and stored at 208C until needed. The
lyophilized RLC was solubilized and dialyzed before exchanging into
muscle ﬁbers as described previously (Roopnarine et al., 1998). Rabbit
skeletal troponin C (TnC) was prepared from rabbit muscle as described
previously (Potter, 1982).
Preparation of muscle ﬁbers
Skinned rabbit psoas muscle was chosen as the background for studying the
effects of the FHC mutations, because this is a well characterized and
reproducible preparation in which RLC extraction and reconstitution has
been extensively studied. The extraction of vRLC from cardiac ﬁbers has not
been reported, and the lack of cysteines in vRLC probably makes DTNB
ineffective in enhancing RLC extraction from muscle ﬁber bundles. Rabbit
psoas ﬁbers were prepared as described previously (Roopnarine and
Thomas, 1995) with the following modiﬁcations: ﬁber bundles (;0.4 cm
in diameter) were incubated in ﬁber storage solution (FSB ¼ 50% v/v Rigor
solution (RS)/glycerol solution (RS: 130 mM potassium propionate, 2 mM
MgCl2, 1 mM EGTA, and 20 mM MOPS, pH 7.0)) for 1 h at 48C. The
solution was then changed three times after 1 h incubations, and ﬁbers stored
at 208C for ;2 weeks before use.
Extraction of RLC and reconstitution with
wildtype RLC or recombinant mutant vRLCs
The untreated ﬁbers (ﬁbers from storage buffer) were dissected into smaller
bundles (;0.2–0.4 mm in diameter), the ends tied with silk thread, placed
inside glass capillaries, and then connected in series to a peristaltic pump for
extraction of RLC, which consisted of the following ﬁve steps. a), The ﬁber
bundles were washed with pre-extraction solution (PES), 20 mM Imidazole
(pH 7.0), 20 mM KCl, 10 mM EDTA, 10 mM CDTA, 2 mM EGTA, for 10
min at 48C; b), then the ﬁber bundles were washed with extraction solution
(ES-PES containing 10 mM DTNB) for 10 min at 258C; then washed with
RS, pH 7; then RS, pH 8, in which MOPS was replaced by EPPS, at 48C. c),
The ﬁber bundles were incubated in RS (pH 8) with 30 mM DTT for 1.5 h at
48C to remove 5-thio-2-nitrobenzoic acid (TNB)-modiﬁed cysteines, and
washed in RS (pH 7) for 10 min. d), TnC (3–5 mg/ml) was re-added to the
ﬁber bundle in RS (pH 7) plus 5 mM MgATP, for 1 h on ice. e), The TnC
solution was removed, the ﬁbers washed with RS (pH 7), then reconstituted
with either the wildtype or mutant RLCs (3–5 mg/ml) in RS (pH 7) for 3 h on
ice. Fibers treated with DTT and TnC were control ﬁbers for experiments
with wildtype rabbit RLC (rRLC) or vRLC, whereas the control ﬁbers for
comparison of the mutant vRLC contained rat vRLC. The unbound RLC
was removed, the ﬁbers were washed with RS (pH 7), washed in FSB so-
lution, and then stored on ice. The complete reversal of TNB-modifed cys-
teines was veriﬁed by measuring the myosin myoﬁbrillar K1- and Ca21-
ATPase activities as described previously (Roopnarine and Thomas, 1994).
The mechanical effects of the chemical treatment during each step (a–c)
on untreated ﬁbers were determined by measuring the Ca sensitivity of
force. The extent of RLC extraction and reconstitution was determined by
densitometric analysis of 15% polyacrylamide urea (Tris-borate) gels
(Biorad, Richmond, CA). The extent of RLC and TnC extraction and
reconstitution were determined from the ratio of RLC/(LC1 1 LC3) and
TnC/(LC1 1 LC3).
Single muscle ﬁber mechanics
Single ﬁbers were dissected from the ﬁber bundles containing recombinant
RLC for mechanical measurements. The force of a skinned muscle ﬁber
(;2–3 mm in length) was measured at 258C using a Muscle Research
System (Scientiﬁc Instruments, Heidelberg, Germany), varying the pCa
(log[Ca21]) from 9.0 to 4.5, using Ca-EGTA buffering as described
previously (Kerrick et al., 1991). The single ﬁber segment was mounted
between two microtweezers, one of which was attached to a force transducer
(Scientiﬁc Instruments, model KG3, range of 0–10 mN), which was
connected to a bridge ampliﬁer (Scientiﬁc Instruments, model BAM4C)
with a full scale of 10 V. A stereomicroscope (Nikon) and video camera
(Panasonic, model BL200) was mounted above the transducer to aid in
mounting of the ﬁber and in ﬁber diameter determination. The force of the
single ﬁber was adjusted to zero in rigor (which did not not change during
relaxation). The sarcomere length of the single ﬁber was set to 2.5 mm, and
the ﬁber diameter was measured at four places along the length of the ﬁber
using a calibrated video monitor system, in order to calculate the cross-
sectional area. The mounted ﬁber was then placed in a quartz cuvette (1 cm
long; Scientiﬁc Instruments, model CU1A) ﬁlled with relaxing solution, low
Ca solution (pCa 9.0), 7 mM EGTA, 3.025 mM MgO, 85 mM KOH, 2 mM
Na2ATP, 163.9 mM proprionic acid (proprionate is the major anion), and
13.2 mM imidazole (pH 7.0). Solution was ﬂowed into the cuvette with
a continous ﬂow peristaltic pump, which was connected to a gradient maker,
and controlled by a pump unit (Scientiﬁc Instruments, model CPER1). The
ﬂowthrough solution from the cuvette was immediately removed by gentle
suction using a vacuum apparatus. In this paper, Ca always refers to the free
calcium ion concentration, [Ca21]. The activating solution, a high Ca
solution (pCa 4.5), consisted of relaxing solution1 6.86 mMCaO. The ﬁber
was pretreated with relaxing solution (pCa 9.0), followed by activating
solution (pCa 4.5) for 5–8 seconds, then in relaxing solution until the
maximal force was reduced to the orginal relaxed levels. Isometric force was
acquired as a function of [Ca], by exposing the ﬁber segment to a gradient of
[Ca] from 109 to 104.5 using a programmable gradient maker (using the
routine AT from the program MUAT, Scientiﬁc Instruments) and peristaltic
pump. The gradient maker consisted of a ﬂowthrough solution chamber
(which is continously stirred), in which ﬁxed volumes of solutions are
simultaneously pumped in and out by a computer-controlled perstaltic
pump. The activating solution was placed in a separate chamber and was
pumped into the chamber containing the relaxing solution. The computer
program controlled the peristaltic pump to make a ﬁxed volume solution
change (step size of 5) at ﬁxed intervals, with a cuvette incubation time of 5 s
to create a linear gradient of [Ca] in the cuvette containing the single ﬁber.
Each pump step corresponded to a speciﬁc [Ca], and recorded force mea-
surement. To ensure that the volume of the solution mixed remained the
same with each step of the pump for different experiments, the volume of
buffer was precisely and periodically measured using different steps.
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Data analysis
The resting force (pCa 9–8) was subtracted from the single ﬁber force pCa
curves, and then normalized to the cross-sectional area of the ﬁber. The
program ORIGIN (Microcal Software, ver. 6.0) was used to determine best
ﬁts of the tension-pCa curves by means of the Levenberg-Marquardt
nonlinear least-squares algorithm. The best ﬁt was determined from the
lowest x2 between the experimental data and ﬁt. The tension P was the force
normalized to cross-sectional area of the ﬁber, and reported as kN/m2.
Individual curves of P versus pCa were ﬁtted to the Hill equation in the form
P ¼ Po/[1 1 10n (pCa50pCa)], Eq. 1, where Po is the maximum tension,
n is the Hill coefﬁcient, and pCa50 is the pCa when P ¼ 0.5 Po. The Hill
coefﬁcient is a measure of the cooperativity of the activation process and
determines the steepness of the tension pCa curve. The tension was
normalized to the value of Po obtained from ﬁts to the Hill equation. There
was variability in the tension pCa curves amongst different rabbit ﬁber
preparations as previously observed (Hofmann et al., 1990), but the relative
changes in pCa50 and n between the different samples remained consistent
with different rabbit ﬁber preparations. As previously observed (Hofmann et
al., 1990), the addition of TnC or wildtype rabbit RLC to treated control
ﬁbers only restored the mechanical properties of the ﬁber to that of the
untreated ﬁbers within a rabbit ﬁber preparation. This is illustrated in Figs.
3–5, which contain data sets from different rabbit ﬁber preparations. The Ca
sensitivity (pCa50) and cooperativity (n) is represented as the difference
between the FHC-RLC ﬁber and wildtype vRLC ﬁber to illustrate the
different sensitivities of the mutant RLCs for each ﬁber preparation.
Statistical analysis
The parameter values (Po, pCa50, n) for each curve were determined by
ﬁtting individual data sets, then the mean 6 SE (shown as error bars) were
calculated. Each tension pCa curve in Figs. 3–5 is the average obtained from
at least two different ﬁber extractions (at least four single ﬁbers from each
preparation were analyzed). The averaged tension pCa curves (in Figs. 3–5)
were also ﬁtted to Eq. 1, to verify the validity of the averaging. Therefore, all
the experimental data is reported as mean 6 SE. The signiﬁcance was
determined by the unpaired Student’s t-test using the program ORIGIN. The
conﬁdence level P\ 0.05 was used for comparison of FHC-RLC ﬁber to
wildtype vRLC ﬁber.
RESULTS
It was ﬁrst necessary to optimize the procedure for RLC
extraction and reconstitution in rabbit psoas ﬁbers, and to
demonstrate that the introduction of cardiac vRLC restores
the physiological properties of the muscle ﬁbers. Previously,
RLC was extracted from skeletal muscle ﬁbers either at
higher temperatures so that reconstitution with rRLC did not
fully restore normal maximal tension (Diffee et al., 1995), or
by using a DTNB extraction method that did not restore
normal Ca sensitivity of the muscle ﬁbers (Szczesna et al.,
1996). The protocol developed in this paper for RLC
extraction and reconstitution with rRLC results in restoration
of maximal tension, Ca sensitivity, and cooperativity of
ﬁbers. Reconstitution of skeletal psoas ﬁbers with rat vRLC
also restored maximal tension, but conferred Ca sensitivity
and cooperativity characteristic of cardiac ventricular muscle
ﬁbers. Cardiac muscle ﬁbers were not used for this study
because the extraction and exchange of RLC into cardiac
muscle ﬁbers have not been reported before, probably
because the lack of cysteines in vRLC makes DTNB
ineffective in extraction.
Protein composition of extracted and
reconstituted ﬁber bundles
The endogenous rabbit RLC (rRLC) was extracted (50 6
8%) from ﬁber bundles, and then replaced with rRLC,
wildtype vRLC, or mutant vRLC. TnC was also removed (80
6 5%) during the extraction procedure (Fig. 2, left, lane 4),
so it was subsequently replaced by the addition of puriﬁed
rabbit skeletal TnC to the ﬁber bundles. vRLC and mutant
vRLCs (except for E22K, which migrated higher than
rRLC) migrates faster than the endogenous rRLC on 15%
polyacrylamide-urea gels (Fig. 2, left), allowing precise
quantitation of the protein bands by densitometric analysis
(Fig. 2, right). The extent of RLC and TnC extraction and
reconstitution was determined from the ratio of RLC/(LC11
LC3) and TnC/(LC1 1 LC3), which are 0.782 6 0.05 and
0.317 6 0.03 for untreated and control ﬁbers (with rRLC),
respectively. Reconstitution with puriﬁed RLC (rRLC, or
vRLC, or mutant vRLC) and TnC restored the RLC and TnC
to normal protein levels (Fig. 2), suggesting that the vRLC
and mutant vRLC binding to skeletal myosin were com-
parable to skeletal RLC. The urea gels also conﬁrm that none
of the RLCs (either rRLC or vRLC) was phosphorylated
in solution or on the ﬁber (phosphorylated RLC migrate fur-
ther down the urea gel than the unphosphorylated RLC).
Analysis of the reconstituted ﬁber bundle on 7–16% gradient
SDS PAGE showed that the sarcomeric protein composition
FIGURE 2 Protein composition of extracted and recon-
stituted ﬁber bundles. (Left) 15% polyacrylamide urea gel
of muscle ﬁber proteins; (lane 1) rabbit skeletal myosin;
(lane 2) puriﬁed rabbit TnC; (lane 3) control muscle ﬁbers;
(lane 4) RLC-extracted muscle ﬁbers; and (lane 5) ﬁbers
reconstituted with vRLC and TnC. (Right) Densitometric
analysis showing the rRLC, vRLC, and TnC content.
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was similar to the untreated ﬁber bundle (data not shown).
Thus the procedure used in the present study results in
a similar extent of protein extraction and reconstitution as
obtained with previous procedures (Diffee et al., 1995;
Szczesna et al., 1996) but the present procedure results in
restoration of physiological performance of the ﬁbers, as
described below.
Functional reconstitution of ﬁbers
Because the depletion of TnC from muscle ﬁbers decreases
the Ca sensitivity (Moss et al., 1985), and DTNB can perturb
Ca sensitivity of ﬁbers (Szczesna et al., 1996), the effects of
the extraction protocol on the mechanical properties of the
ﬁbers were determined at different experimental steps
(see Materials and Methods) that had the potential to modify
the ﬁber integrity. Incubation of ﬁbers in step c alone (DTT
treatment) decreased Ca sensitivity slightly (Fig. 3, open
circles; Table 1, untreated 1 DTT), compared to untreated
ﬁbers (Fig. 3, squares), but addition of TnC (step d ) restored
the Ca sensitivity (Fig. 3, closed circles; Table 1, untreated
1 DTT 1 TnC). Prior to RLC extraction, the ﬁbers were
incubated in a pre-extraction solution (PES) in step (a) to
enhance removal of divalent cations to weaken the in-
teraction between the RLC and myosin heavy chain to fa-
cilitate RLC extraction. Treatment of ﬁbers with both steps
a and c decreased Ca sensitivity (Fig. 3, closed triangles;
Table 1, untreated 1 PES 1 DTT) to a greater extent than
with step c alone, but addition of TnC (step d) restored the Ca
sensitivity (Fig. 3, open triangles; Table 1, untreated 1 PES
1 DTT 1 TnC). Urea gel analysis of these ﬁber samples
conﬁrmed the partial extraction and complete restoration of
TnC (data not shown). Therefore, all ﬁber bundles were
incubated with TnC after the DTT treatment of the ﬁbers to
restore normal function.
Inclusion of 10 mM DTNB in the extraction solution (ES,
step b) additionally removed RLC from the ﬁbers (Fig. 4,
triangles). Removal of both RLC and TnC from the muscle
ﬁber resulted in ;50% decrease of maximal isometric
tension and severe loss of Ca sensitivity (data not shown).
Reconstitution of the RLC/TnC-depleted ﬁbers with puriﬁed
TnC restored tension to 80 6 5%, consistent with previous
studies (Moss et al., 1985), but not normal Ca sensitivity
(Fig. 4, triangles; Table 2, ES 1 DTT 1 TnC). Subsequent
reconstitution of these ﬁbers with rabbit RLC restored the
Ca-dependent force (Fig. 4, squares; Table 2, rRLC) to
FIGURE 3 Effect of TnC reconstitution on the Ca dependence of
normalized single ﬁber tension. Untreated ﬁbers (n) compared to ﬁbers
treated to different experimental steps in the extraction protocol: step c, DTT
(); steps c and d, DTT1 TnC (d); steps a and c, pre-extraction solution1
DTT (m); pre-extracted solution 1 DTT 1 TnC (n). Curves show best ﬁts
to Eq. 1. The data and curves are averages of four ﬁber samples from two
different ﬁber preparations.
TABLE 1 Mechanical parameters for single muscle ﬁbers
for Fig. 3
Fiber sample Maximal tension pCa50 n (Hill coefﬁcient)
Untreated 255.68 6 9.02 5.83 6 0.077 3.71 6 0.082
Untreated 1 DTT 252.446 6 5.08 5.81 6 0.009 4.02 6 0.333
Untreated 1 DTT
1 TnC (control)
271.28 6 15.0 5.84 6 0.029 3.00 6 0.159
Untreated 1 PES
1 DTT
253.848 6 19.88 5.66 6 0.051 2.80 6 0.378
Untreated 1 PES
1 DTT 1 TnC
284.69 6 20.50 5.89 6 0.03 4.28 6 0.12
The tension is reported as kN/m2. The values are the mean 6 SE for four
single ﬁbers from two preparations. Untreated ¼ ﬁbers from storage buffer.
The experimental conditions for ﬁbers treated with DTT, TnC, and PES
(pre-extraction solution) are given in Materials and Methods. Untreated
ﬁbers incubated with DTT and TnC were deﬁned as control ﬁbers for the
experiments described below.
FIGURE 4 Effect of RLC extraction and reconstitution on the Ca-
dependence of ﬁber tension. Control (d), RLC-depleted (n), reconstituted
with rRLC (), and reconstituted with vRLC (e). Curves show best ﬁts to
Eq. 1. The data and curves are averages of four single ﬁbers from two
preparations.
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normal levels of control ﬁbers (ﬁbers treated with DTT and
TnC, Fig. 4, circles). This study shows that the procedure
used for RLC extraction and reconstitution results in the
exchange of;50% of the endogenous RLC, and completely
restores normal physiological properties, as measured by Ca
sensitivity and cooperativity (n), as well as maximal tension.
Reconstitution of the RLC ﬁbers with vRLC (Fig. 4,
diamonds; Table 2, vRLC) restores maximal tension and
increased Ca sensitivity to a level that is even higher than in
the original psoas ﬁbers. In fact, the level of Ca sensitivity is
similar to that observed for cardiac ventricular ﬁbers
(Gordon et al., 2001; Martyn and Gordon 2001), suggesting
that Ca sensitivity depends, in part, on the source of RLC.
This leftward shift in the Ca sensitivity is not due to
phosphorylation of RLC (either the remaining endogenous
rabbit RLC or vRLC) since the lower migrating RLC species
(typical of phosphorylated RLC) were not observed on urea
gels. The amino acid sequence identity of rat vRLC and
rabbit skeletal RLC is only 73.2% (87% similarity), so the
difference probably contributes to, in part, the less steep
tension pCa curve characteristic of cardiac ﬁbers (Gordon
et al., 2001).
Mechanical function of FHC-RLC mutants
The mean maximal tension (determined from ﬁts to Hill
equation) was not signiﬁcantly affected for ﬁbers with G13T,
E22K, or P95A, whereas ﬁbers with F18L have substantially
decreased tension (69 6 10%) compared to ﬁbers with
wildtype vRLC (Po ¼ 229.426 16.24; see Fig. 5, A and B).
The tension at pCa 6.0 (Fig. 5 A, vertical dotted line and
Fig. 5 D) was not signiﬁcantly affected for the ﬁbers with
P95A, but was signiﬁcantly increased for ﬁbers with E22K,
and decreased for G13T and F18L (Fig. 5 D).
The pCa50 value, which represents the ﬁber sensitivity to
Ca21 at half-maximal activation (Fig. 5 C, horizontal dotted
line), was affected for all the FHC-RLC mutants except
P95A, which was similar to the ﬁbers with wildtype vRLC
(pCa50 ¼ 5.966 0.008; see Figs. 5 C and 6, top panel). The
pCa50 for E22K mutant increased, suggesting increased Ca
sensitivity for this mutation. The G13T mutant induced
a decrease in Ca sensitivity (pCa50 is decreased), whereas
F18L induced an even further decrease in Ca sensitivity. The
Hill coefﬁcient (cooperativity) for ﬁbers with G13T, E22K,
and P95A was not signiﬁcantly different from ﬁbers with
wildtype RLC (n ¼ 1.91 6 0.057; see Fig. 6, lower panel).
TABLE 2 Mechanical parameters for single muscle ﬁbers
for Fig. 4
Fiber sample Maximal tension pCa50 n (Hill coefﬁcient)
Untreated 1 DTT
1 TnC
279.67 6 13.63 6.289 6 0.071 4.670 6 0.47
ES 1 DTT
1 TnC
224.30 6 26.25 6.183 6 0.004 1.601 6 0.045
rRLC 1 DTT
1 TnC
270.24 6 15.23 6.310 6 0.048 3.154 6 0.021
vRLC 1 DTT
1 TnC
275.31 6 18.51 6.515 6 0.015 2.244 6 0.144
The tension is reported as kN/m2. The values are the mean 6 SE for four
single ﬁbers from two preparations. The difference pCa50 for the untreated
1 DTT 1 TnC ﬁbers in Table 2 compared with Table 1 is explained in
Materials and Methods. ES 1 DTT 1 TnC ﬁbers are rRLC-depleted ﬁbers;
rRLC1 DTT1 TnC are ﬁbers reconstituted with rabbit RLC; and vRLC1
DTT 1 TnC are ﬁbers reconstituted with rat vRLC.
FIGURE 5 Ca-dependence of tension of
single muscle ﬁbers reconstituted with either
wildtype or FHC-vRLC mutants. Wildtype (d)
vRLC; compared to FHC-mutant RLC: G13T
(e); F18L (n); E22K (); and P95A (). (A)
Averaged tension (P) versus pCa 9–4.5; (B)
mean maximal tension mean 6 SE from ﬁts to
Eq 1; (C) averaged normalized tension (P/P0)
versus pCa; (D) mean tension mean 6 SE at
pCa 6.0. Curves inA andC are best ﬁts to Eq 1.
* ¼ P\0.05; n.s. ¼ not signiﬁcantly different
from wildtype. The data and curves are
averages of the single ﬁber tension pCa curves
from four ﬁbers from two preparations.
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However, the Hill coefﬁcient for F18L was most severely
decreased compared to the other mutations, characteristic of
RLC-extracted ﬁbers despite complete restoration of the
RLC content of the F18L in the ﬁbers.
DISCUSSION
This is the ﬁrst study to show that the replacement of rabbit
RLC with rat vRLC in rabbit psoas ﬁbers was successful
in that the maximal tension of single muscle ﬁbers was
restored. This study also shows that myosin FHC-RLC
mutants impair the mechanical function of muscle ﬁbers. The
RLC mutants display a range of effects in which the Ca
sensitivity of contracting ﬁbers were increased (E22K),
decreased (G13T and F18L), or not signiﬁcantly affected
(P95A). The maximal tension and cooperativity were not
signiﬁcantly affected for the RLC mutants, except for F18L,
which was signiﬁcantly lowered.
A unique feature of this study is that mutant RLC was
introduced into normal muscle ﬁbers, so the effects observed
are directly related to the function of myosin, and are not
complicated by slowly developing secondary effects (e.g.,
cellular disarray, ﬁbrosis, necrosis, hypertrophy) that are
often associated with cardiac tissue from diseased patients or
transgenic animals. Another advantage of this in vitro study
is that the amount of mutant RLC in the muscle ﬁber could
be quantitated by gel electrophoresis, in contrast to studies
that use diseased human tissue that most likely contains
a mixture of mutant and normal vRLC. These results dem-
onstrate that the mutant proteins induce functional defects
that are immediate; i.e., that secondary morphological
changes do not have to occur before the ﬁber’s func-
tional integrity is impaired by the mutation. A potential
limitation of the present study is that a direct correlation of
the functional defects of the FHC-RLC mutations in skeletal
muscle to that in cardiac muscle must be made cautiously,
because although the basic mechanisms for contraction in
skeletal and cardiac muscle are similar, there are key
differences in the roles of some thick and thin ﬁlament
proteins.
The amino acid sequence identity of rat vRLC compared
to human vRLC is 95.2%, so it is highly probable that the
human FHC-RLC mutations in the rat cardiac RLC will
faithfully report functional consequences of the FHC-RLC
mutations on muscle contraction. Furthermore, transgenic
mice with myosin FHC mutations have proven to be useful
models of the FHC disease (Seidman and Seidman, 2001;
Sanbe et al., 2000). Skeletal muscle was chosen as the
background for studying the effects of FHC mutations,
because the methodologies for extraction and exchange of
mutant RLC, and for mechanical analysis of skinned muscle
ﬁbers, have been much more successfully developed in
skeletal than in cardiac muscle. This study required a robust
preparation of skinned ﬁbers that could stand up to extensive
biochemical manipulation and give reproducible mechanical
results; rabbit psoas muscle meets these requirements.
Although there are amino acid differences between the
skeletal and cardiac RLC isoforms (73% identity), the cardiac
vRLC is able to restore Ca-sensitive isometric tension in
skeletal muscle ﬁbers (Fig. 4). Indeed, the observed Ca
sensitivity of tension appears to be inﬂuenced by the RLC
source—whereas normal function is restored by addition of
rabbit skeletal RLC (Fig. 4), the addition of cardiac vRLC
confers increased Ca sensitivity with a lower Hill coefﬁcient
(Fig. 4), reminiscent of cardiac muscle (Martyn and Gordon,
2001). Ideally, it would bemore appropriate to study the effect
of the FHC-RLC mutations in the context of human cardiac
muscle, but the availability of sufﬁcient healthy tissue for
the functional studies is limited. Although there are some
differences in the mechanisms for contraction between
cardiac and skeletal muscle, the key elements remain similar.
In fact, since vRLC confers physiological properties of
cardiac muscle in rabbit psoas ﬁbers, it is likely that the
functional perturbations caused by vRLC mutations in the
present study reﬂect their effect in cardiac muscle.
FIGURE 6 Ca sensitivity (pCa50 ¼ pCa at half-maximal tension) and
cooperativity (n) of single ﬁbers containing wildtype vRLC, FHC-vRLC
mutants, or 50% rRLC. The Ca sensitivity and cooperativity are plotted as
the difference between the FHC-vRLC mutants and wildtype determined
from the data in Fig. 5. The data are presented as the mean 6 SE. *, P\
0.05; n.s., not signiﬁcantly different from wildtype vRLC.
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Functional reconstitution of muscle ﬁbers
Removal of 50% RLC from skeletal muscle ﬁbers decreases
the maximal tension and Ca sensitivity of force, but re-
constitution with skeletal RLC completely restores normal
function (Fig. 4), to an extent that has not been previously
reported (Diffee et al., 1995; Szczesna et al., 1996). Re-
placement of skeletal RLC with ventricular RLC also re-
stores maximal tension to normal levels, and induces Ca
sensitivity (increased) and cooperativity (decreased) (Fig. 4)
similar to that of native cardiac ﬁbers (Gordon et al., 2001;
Martyn and Gordon, 2001). This ability of RLC to confer
tissue-speciﬁc Ca sensitivity in ﬁbers was observed pre-
viously for smooth muscle RLC, which increased Ca
sensitivity of skeletal muscle ﬁbers (Levine et al., 1998).
Similarly, partial replacement of vRLC by skeletal rRLC in
the hearts of transgenic mice reduced left ventricular
contractility and the rate of relaxation of perfused hearts
(Gulick et al., 1997).
G13T decreases Ca sensitivity
The G13T mutation does not signiﬁcantly affect the maximal
isometric tension (at saturating Ca) or the cooperativity, but
it reduces force at subsaturating Ca, decreasing the Ca
sensitivity (Figs. 5 and 6). This is a physiologically signi-
ﬁcant defect, since the contracting heart spends most of its
time at subsaturating Ca concentrations, where force is
submaximal. As mentioned in Materials and Methods, the
N-terminus of rat vRLC contains four different amino acids
compared to human vRLC: Gly13Ala, Leu10Ala, Glu11Ala,
and Ser14Asn (the rat’s amino acid precedes the human’s).
Therefore, it is difﬁcult to make a direct correlation between
the mechanical defect in muscle ﬁbers caused by rat G13T-
vRLC and the phenotype of the human FHC disease. Never-
theless, it is quite interesting that this mutation (threonine), at
the precise location (residue 13) where a mutation causes
human disease, causes a signiﬁcant physiological pertur-
bation.
F18L decreases tension, Ca sensitivity,
and cooperativity
The F18L mutation induced a more severe dysfunction,
decreasing maximal tension as well as Ca sensitivity and
cooperativity (Figs. 5 and 6). Indeed, ﬁbers reconstituted
with F18L-RLC have functional properties similar to those
of RLC-extracted ﬁbers, indicating that F18L-RLC is the
only mutant in this study that fails to fully restore any
function. In good correlation with our mechanical measure-
ments, F18L induces the most severe disease phenotype—
the percentage of healthy carriers with this mutation is only
20%, substantially lower than for the other mutations studied
(Flavigny et al., 1998).
E22K increases Ca sensitivity
E22K increases the Ca sensitivity, without affecting maximal
tension and cooperativity of contracting muscle ﬁbers (Figs.
5 and 6). This increased Ca sensitivity is similar to results of
a previous study with deltoid muscle ﬁbers from a diseased
patient with the E22K mutation (Levine et al., 1998). The
latter study shows an increase in Ca sensitivity over the
whole range of activation levels, whereas in the present
study, the Ca sensitivity increases above pCa10 (10% of
maximal tension; see Fig. 5, A and C; Fig. 6, top panel ).
Similarly, the cooperativity of force activation was not
signiﬁcantly changed (Fig. 6, lower panel) as in the previous
study (Levine et al., 1998). These results suggest that the
FHC mutation, E22K, in rat vRLC in rabbit psoas muscle
shows similar physiological effects as the FHC mutation in
human vRLC in slow skeletal muscle. In the present study,
50% E22K-vRLC is exchanged in the muscle ﬁbers, whereas
in the previous study with deltoid muscle from a diseased
patient, the amount or identity of the RLC mutant in the
muscle ﬁber was not determined. Electron microscopy of
myosin ﬁlaments extracted from the affected deltoid ﬁbers
showed increased ﬁlament disorder compared to normal
thick ﬁlaments, suggesting that E22K promotes head
movement away from the thick ﬁlament, which might
explain the increased activation at low Ca (Levine et al.,
1998). Despite these effects of E22K on ﬁber mechanics and
human disease, myosin extracted from diseased deltoid
muscle ﬁbers from a patient with the E22K mutation pro-
duced normal in vitro actin ﬁlament motility (Poetter et al.,
1996). In addition, transgenic mice with the E22K-RLC
mutation did not display any of the typical phenotypic
features of the human disease, despite total replacement of
the endogenous vRLC with mutant vRLC (Sanbe et al.,
2000). Thus, single-ﬁber mechanics is more sensitive than
some other assays in detecting the functional defect caused
by this mutation.
P95A has no signiﬁcant effect on tension,
Ca sensitivity, or cooperativity
P95A does not induce signiﬁcant changes in the maximal
tension, Ca sensitivity, or cooperativity of contracting ﬁbers
(Figs. 5 and 6). This mutation in the linker region between
the N- and C-terminal domains of RLC is expected to
increase ﬂexibility of that region (Rayment et al., 1993).
Indeed, it has been shown that deletion of the equivalent
proline residue in smooth myosin RLC activates myosin
ATPase activity (Ikebe et al., 1998). However, the present
study shows clearly that the P95A mutation, which probably
increases ﬂexibility of the linker region, is not sufﬁcient to
affect the Ca-dependence of isometric tension. Thus, the
mechanism whereby this mutation causes FHC must involve
some function other than isometric force generation, such as
the rate of contraction.
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Mechanistic hypotheses
In most current models of muscle contraction, the LC
domain acts as a rigid lever arm that undergoes a large
rotation during the transition of weakly- to strongly-bound
myosin heads on the actin ﬁlament. The potential fragility of
this lever arm is suggested by the crystal structure of the
myosin head, which shows that the LC domain is based on
a single long, slightly curved a-helix that extends from the
catalytic domain and binds the ELC and RLC (Rayment
et al., 1993). It is likely that the mechanical stability of the
LC domain depends on the structural integrity of the light
chains, so it is plausible that structural perturbations in the
RLC can alter isometric tension by changing the number of
strong binding heads during contraction. An increase in the
number of strong binding heads is itself capable of increas-
ing thin ﬁlament activation that will increase both Ca sensitiv-
ity and cooperativity (Gordon et al., 2001). The reduction in
Ca sensitivity of the G13T and F18L mutations suggests that
the number of strong binding crossbridges was reduced dur-
ing contraction, whereas the increase in Ca sensitivity by
E22K increases this fraction.
It was previously shown that a point mutation (D47A)
in the Ca21/Mg21 binding site of RLC reduced Ca binding,
Ca sensitivity, and cooperativity of contracting ﬁbers (Diffee
et al., 1995). Furthermore, D47A decreased ﬁber stiffness, but
increased the rate of force redevelopment and rate of
relaxation of activated ﬁbers after chelating Ca21, suggesting
that D47A decreases the proportion of cycling crossbridges
in the force-generating state by decreasing the rate of forma-
tion of force-generating bridges and increasing the rate of
detachment (Diffee et al., 1995). Thus the previously ob-
served effects of RLC on the Ca dependence of force (Levine
et al., 1998; Diffee et al., 1995; Gulick et al., 1997) are prob-
ably due to changes induced by RLC on in the number of
strong binding heads.
Several FHC-vRLC mutations used in the present study
were examined previously in a study of Ca binding to isolated
light chains in solution (Szczesna et al., 2001). Mutations
A13T, F18L, and P95A decreased the Ca binding afﬁnity by
;3-fold, whereas E22K decreased it by 17-fold. These results
do not correlate qualitatively with the functional effects on
ﬁbers observed in the present study, suggesting that changes
in Ca afﬁnity do not provide a simple explanation of our
observations. For example, a mutation might affect force by
affecting the structural integrity of the LC domain, modifying
its effectiveness as a lever arm. However, it is important to
note that the conformational order and Ca-binding afﬁnity of
isolated RLCs in solution is probably much less than when
bound to myosin in ﬁbers, so a simple correlation with ﬁber
function is not really expected.
Mechanisms of FHC disease
The present results show that;50%mutant RLC is sufﬁcient
to perturb the tension at subsaturating Ca concentration
(Fig. 5 D), Ca sensitivity, and cooperativity of force
generation of ﬁbers (Fig. 6), supporting the hypothesis that
the mechanical dysfunction of the ﬁbers may be directly
linked to the mechanism for FHC. The enhanced (E22K) and
diminished (G13T and F18L) function of these FHC-RLC
mutations ﬁbers suggest that the FHC disease may be caused
by ﬁbers that are in either a hypercontractile (E22K) or
hypocontractile (G13T and F18L) state. Previous reports also
suggest that different FHCmutations can induce either a gain
or loss of function (Roopnarine, 2002; Bonne et al., 1998;
Seidman and Seidman 2001; Hernandez et al., 2001; Michele
and Metzger, 2000). The dysfunction caused by the FHC-
RLC mutants suggest that the mutant protein will alter the
force generated in myocytes and lead to mechanical stress
within the heart, which is likely to cause myocyte disarray
and remodeling of the heart via hypertrophy.
This study shows that wildtype ventricular RLC confers
Ca-sensitive force in skeletal muscle similar to that of cardiac
muscle. Of the four FHC-RLC mutants tested, three caused
immediate and substantial changes in the Ca sensitivity of
force production, suggesting that these mechanical abnor-
malities initiate the FHC disease process.
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